Compounding: FDA Stepping Up Enforcement With Warning Letters?

From BioPharma Today
September 3, 2013 - 5:25pm

FDA calls North Carolina compounder’s products misbranded and adulterated after the company did not receive valid prescriptions for a number of products it made and agency found several GMP violations.

Continue reading this article »

Compounding: FDA Stepping Up Enforcement With Warning Letters? http://ewallstreeter.com/compounding-fda-stepping-up-enforcement-with-warning-letters-5761/#ixzz2dt26mYEo